Aller au contenu
Logo PhinC Development
  • Home
  • About

    About PhinC Develpment

    Quantitative pharmacology solutions to optimize your drug development.

    Façade immeuble de PHINC Development à Massy

    Our history

    Our values

    Quality

    Our news

  • Expertise

    MIDD

    Drug-Drug Interactions (DDI) analysis

    Integrated modeling for drug development

    Physiologically-Based Pharmacokinetic modeling

    Population Pharmacokinetics

    QT / QTc Analysis

    Support

    PK Statistics Studies

    Target-Mediated Drug Disposition

    CDISC compliance of PK Data

    Filling for health agencies

    Pharmacokinetics NCA

    Biotech Boost

    Integrated Phase 1 Solutions

  • Resources
  • Careers
  • Contact
  • Client area

Author: Mohamed Taourirt

[Webinar] Translational Mechanistic Modeling : Applications for ADCs

PhinC Development is pleased to host an exclusive webinar dedicated to Translational Mechanistic Modeling: Applications for Antibody Drug Conjugates (ADCs). Discover how Model-Informed Drug Development (MIDD) strategies can accelerate and de-risk ADC programs.

10 good reasons to use modeling and simulation

Modeling expertise is an essential building block for an optimal drug development strategy.

Logo PhinC Development

Headquarters

PhinC Development
36 Rue Victor Basch
Immeuble Le Classea
91300 MASSY
FRANCE
Tel : +33 1 76 91 24 60

North America Office

PhInc. Modeling
625 Av. du Président-Kennedy Suite 950
Montréal QC Québec H3A 1K2
CANADA
Tel : +1 514 245 4848

Subscribe to newsletter
  • Privacy policy
  • Privacy Policy on Personal Data - Applicants
  • Legal notice
  • Privacy policy
  • Privacy Policy on Personal Data - Applicants
  • Legal notice
Change language to Français